Addictions, Drug & Alcohol Institute
Addictions, Drug & Alcohol Institute > ADAI Publications

ADAI Publications

1331 publications found

  1. Irwin AN, Bratberg J, Al-Jammali Z, Arnold J, Gray M, Floyd AS, Boliver D, Hansen R, Hartun DM, Green TC. Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician. Journal of the American Pharmacists Association 2023;63(1):284-294.e1. [doi: 10.1016/j.japh.2022.12.001] PMID: 36567216 PMCID: PMC9933140
  2. Hall W, Leung J, Carlini BH. Do not let the ideal be the enemy of good enough regulation [commentary]. Addiction 2023;118(6):1009-1010. [doi: 10.1111/add.16201]
  3. Owens MD, Banta-Green CJ, Newman A, Marren R, Takushi R. Insights into a recovery community center model: Results from qualitative interviews with staff and member facilitators from Recovery Cafe in Seattle, Washington. Alcoholism Treatment Quarterly 2023; 41(1):62-75. [doi: 10.1080/07347324.2022.2088323]
  4. Stoner SA, Graham JC, Grant TM. Evaluating outcomes of a three-year case management program for mothers with prenatal substance use according to race/ethnicity, Washington State, 2006–2017. BMC Public Health 2023;23:1832. [doi: 10.1186/s12889-023-16670-z] PMID: 37730578 PMCID: PMC10512570
  5. Boyle HK, Singh S, Lopez G, Jackson KM, Carey KB, Merrill JE. Insights into the context of simultaneous alcohol and cannabis use among young adults. Experimental and Clinical Psychopharmacology 2023;31(3):662-673. [doi: 10.1037/pha0000607] PMID: 36174141 PMCID: PMC10201978
  6. Trinidad SB, Shane AL, Guinn TR, Apok CR, Collier AF, Avey JP, Donovan DM. Cultural adaptation of a sobriety support app for Alaska Native and American Indian people: A qualitative study. JMIR Formative Research 2023;7:e38894. [doi: 10.2196/38894] PMID: 36473107 PMCID: PMC9944154
  7. Salow K, Jack HE, Tinsley J, Banta-Green CJ, Kingston S, Iles-Shih M, Tsui J, Glick S. Racial disparities in use of syringe service programs in King County, WA: A comparison of two cross-sectional surveys. Harm Reduction Journal 2023;20:133. [doi: 10.1186/s12954-023-00868-w] PMID: 37704989 PMCID: PMC10500904
  8. Hancock C, Johnson A, Sladky M, Chen LL, Shushan S, Parchman ML. Integrating MOUD and primary care: Outcomes of a multicenter learning collaborative. Family Medicine 2023;55(7):452-459. [doi: 10.22454/FamMed.2023.643371] PMID: 37450845 PMCID: PMC10622073
  9. Dillard DA, Hebert LE, Shaw JL, Trinidad SB, Dirks LG, Lillie K, Ludman EJ, Donovan D, Burke W. Measuring attitudes about alcohol misuse and dependence among Alaska Native people within a tribal health care system. Journal of Addiction Medicine 2023;17(1):e42-e48. [doi: 10.1097/ADM.0000000000001040] PMID: 36166685
  10. Peavy KM. How to ask if they’re getting addicted. Worried about someone’s drinking or drug use, but not sure what to say? There’s a counselling approach that can help. Psyche (website) 2022; April 8
  11. Kingston S, Banta-Green C. Care Navigation at Harm Reduction Programs: Community-Based “Meds First” Buprenorphine Program Preliminary Data. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, June 2022
  12. Hall K, Higgins F, Beach KF, Diriba K, Sladky M, McCall TC. Disruptions to U.S. local public health’s role in population-based substance use prevention and response during COVID-19. Substance Abuse Treatment, Prevention, and Policy 2022;17(1):73. [doi: 10.1186/s13011-022-00499-7] PMID: 36345019 PMCID: PMC9640804
  13. Rosales R, Janssen T, Yermash J, Yap KR, Ball EL, Hartzler B, Garner BR, Becker SJ. Persons from racial and ethnic minority groups receiving medication for opioid use disorder experienced increased difficulty accessing harm reduction services during COVID-19. Journal of Substance Abuse Treatment 2022;132:108648. [doi: 10.1016/j.jsat.2021.108648] PMID: 34742607 PMCID: PMC8566093
  14. Braciszewski JM, Idu AE, Yarborough BJH, Stumbo SP, Bobb JF, Bradley KA, Rossom RC, Murphy MT, Binswanger IA, Campbell CI, Glass JE, Matson TE, Lapham GT, Loree AM, Barbosa-Leiker C, Hatch MA, Tsui JI, Arnsten JH, Stotts A, Horigian V, Hutcheson R, Bart G, Saxon AJ, Thakral M, Grant DL, Pflugeisen CM, Usaga I, Madziwa LT, Silva A, Boudreau DM. Sex differences in comorbid mental and substance use disorders among primary care patients with opioid use disorder. Psychiatric Services 2022;73(12):1330-1337. [doi: 10.1176/appi.ps.202100665] PMID: 35707859 PMCID: PMC9722542
  15. Firth CL, Warren KM, Perez L, Kilmer B, Shih RA, Tucker JS, D'Amico EJ, Pedersen ER. Licensed and unlicensed cannabis outlets in Los Angeles County: The potential implications of location for social equity. Journal of Cannabis Research 2022;4:18. [doi: 10.1186/s42238-022-00120-5] PMID: 35410443 PMCID: PMC8996577
  16. Hatch MA, Wells EA, Masters T, Beadnell B, Harwick R, Wright L, Peavy M, Ricardo-Bulis E, Wiest K, Shriver C, Baer JS. A randomized clinical trial evaluating the impact of counselor training and patient feedback on substance use disorder patients’ sexual risk behavior. Journal of Substance Abuse Treatment 2022;140:108826. [doi: 10.1016/j.jsat.2022.108826] PMID: 35751944
  17. Owens MD, Ngo S, Grinnell S, Pearlman D, Bekemeier B, Cusworth Walker S. Co-producing evidence-informed criminal legal re-entry policy with the community: an application of policy codesign. Evidence & Policy 2022;18(2):356-375. [doi: 10.1332/174426421X16445109542161]
  18. Eakins D, Magarati M, Hess K, Egashira L, Singer S, Parker M. Tailoring Opioid Overdose Prevention for Diverse Groups within Tribal and Urban Indian Settings. A Toolkit for Providers and Community Organizations Serving American Indian/Alaska Native Communities. Seattle, WA: Seven Directions, University of Washington, March 2022, 75p.
  19. Wadsworth E, Schauer GL, Hammond D. Home cannabis cultivation in the United States and differences by state-level policy, 2019-2020. American Journal of Drug and Alcohol Abuse 2022;48(6):701-711. [doi: 10.1080/00952990.2022.2132507] PMID: 36288408
  20. Schauer GL, Roehler DR, Hoots BE. Self-reported medical and nonmedical cannabis use: Results from the 2018 Behavioral Risk Factor Surveillance System in 14 states. Journal of Community Health 2022;47:641-649. [doi: 10.1007/s10900-021-01049-1] PMID: 35460471 PMCID: PMC9884044
  21. Eakins DR, Neilson EC, Stappenbeck CA, Nguyen HV, Davis KC, George WH. Alcohol intoxication and sexual risk intentions: Exploring cultural factors among heavy drinking women. Addictive Behaviors 2022;131:107314. [doi: 10.1016/j.addbeh.2022.107314] PMID: 35381432 PMCID: PMC9271756
  22. Banta-Green CJ, Owens MD, Williams JR, Sears JM, Floyd AS, Williams-Gilbert W, Kingston S. The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State. Addiction Science & Clinical Practice 2022;17:34. [doi: 10.1186/s13722-022-00315-4] PMID: 35799210 PMCID: PMC9261214
  23. Moore KE, Siebert SL, Kromash R, Owens MD, Allen D. Negative attitudes about medications for opioid use disorder among criminal legal staff. Drug and Alcohol Dependence Rep 2022;3:100056. [doi: 10.1016/j.dadr.2022.100056] PMID: 36845981 PMCID: PMC9948914
  24. Dunbar MS, Seelam R, Tucker JS, Firth CL, Pedersen ER, Klein DJ, Rodriguez A, D'Amico EJ. Patterns and correlates of cannabidiol product and marijuana co-use in a sample of U.S. young adults. Addictive Behaviors 2022;126:107185. [doi: 10.1016/j.addbeh.2021.107185] PMID: 34839070 PMCID: PMC8802812
  25. Rhee JU, Vieira VM, Firth CL, Pedersen ER, Dunbar MS, Timberlake DA. Concentration of cannabis and tobacco retailers in Los Angeles County, California: A spatial analysis of potential effects on youth and ethnic minorities. Journal of Studies on Alcohol and Drugs 2022; 83(4): 502-511. [doi: 10.15288/jsad.2022.83.502] PMID: 35838427 PMCID: PMC9318698
  26. Banta-Green C, Williams J. Overdose Deaths Involving Pharmaceutical Opioids in Washington State from 2010-2021. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, November 2022
  27. Lee CM, Calhoun BH, Abdallah DA, Blayney JA, Schultz NR, Brunner M, Patrick ME. Simultaneous alcohol and marijuana use among young adults: A scoping review of prevalence, patterns, psychosocial correlates, and consequences. Alcohol Research: Current Reviews 2022;41(1). PMID: 35548267 PMCID: PMC9059839
  28. Carlini BH, Schauer GL. Cannabis-only use in the USA: Prevalence, demographics, use patterns, and health indicators. Journal of Cannabis Research 2022;4:39. [doi: 10.1186/s42238-022-00143-y] PMID: 35864553 PMCID: PMC9306107
  29. Coles CD, Grant TM, Kable JA, Stoner SA, Perez A, Collaborative Initiative on Fetal Alcohol Spectrum Disorders. Prenatal alcohol exposure and mental health at midlife: A preliminary report on two longitudinal cohorts. Alcohol: Clinical & Experimental Research 2022;46(2):232-242. [doi: 10.1111/acer.14761] PMID: 35157325 PMCID: PMC8867925
  30. Perez LG, Tucker JS, Pedersen ER, Troxel WM, Rodriguez A, Firth CL, Seelam R, Shih RA, D'Amico EJ. Neighborhood social environment change in late adolescence predicts substance use in emerging adulthood. Health & Place 2022;75:102807. [doi: 10.1016/j.healthplace.2022.102807] PMID: 35512503 PMCID: PMC10519144
  31. Dilley J, Firth C, Kilmer B. Cannabis legalization in Washington: Policy evolution and emerging evidence from the first nine years. IN: Pardal M (ed.). THE CANNABIS SOCIAL CLUB. Abingdon, UK: Routledge, 2023, pp. 155-186
  32. Green TL, Bratberg J, Irwin AN, Boggis J, Gray M, Leichtling G, Bolivar D, Floyd A, Al-Jammali Z, Arnold J, Hansen R, Hartung D. Study protocol for the Respond to Prevent Study: A multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in community pharmacies. Substance Abuse 2022;43(1):901-905. [doi: 10.1080/08897077.2021.2010162] PMID: 35213293 PMCID: PMC9720900
  33. Simpson TL, Kaysen DL, Fleming CB, Rhew IC, Jaffe AE, Desai S, Hien DA, Berliner L, Donovan D, Resick PA. Cognitive processing therapy or relapse prevention for comorbid posttraumatic stress disorder and alcohol use disorder: A randomized clinical trial. PLOS One 2022;17(11):e0276111. [doi: 10.1371/journal.pone.0276111] PMID: 36445895 PMCID: PMC9707793
  34. Bhatraju EP, Fuller C, Grekin P, Rockman S, Peavy KM. Mortality in an opioid treatment program. Journal of Psychoactive Drugs 2022;54(1):93-98. [doi:10.1080/02791072.2021.1909189] PMID: 33840354
  35. Lapham GT, Matson TE, Carrell DS, Bobb JF, Luce C, Oliver MM, Ghitza UE, Hsu C, Browne KC, Binswanger IA, Campbell CI, Saxon AJ, Vandrey R, Schauer GL, Pacula RL, Horberg MA, Bailey SR, McClure EA, Bradley KA. Comparison of medical cannabis use reported on a confidential survey vs. documented in the electronic health record among primary care patients. JAMA Network Open 2022;5(5):e2211677. [doi:10.1001/jamanetworkopen.2022.11677] PMID: 35604691 PMCID: PMC9127557
  36. O'Neal TJ, Bernstein MX, MacDougall DJ, Ferguson SM. A conditioned place preference for heroin is signaled by increased dopamine and direct pathway activity and decreased indirect pathway activity in the nucleus accumbens. Journal of Neuroscience 2022;42(10):2011-2024 [doi: 10.1523/JNEUROSCI.1451-21.2021] PMID: 35031576 PMCID: PMC8916759
  37. Doonan SM, Johnson JK, Firth C, Flores A, Joshi S. Racial equity in cannabis policy: Diversity in the Massachusetts adult-use industry at 18-months. Cannabis 2022;5(1):30-41 [doi: 10.26828/cannabis/2022.01.004] PMID: 37287662 PMCID: PMC10212236
  38. Firth C. Calls to Washington Poison Center for Intentional Exposure to Cannabis, 2017-2021. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, August 2022
  39. Kingston S, Newman A, Banta-Green C. Results from the 2021 WA State Syringe Service Program Health Survey. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, March 2022
  40. Nakata KG, Yin E, Sutlief E, Ferguson SM. Chemogenetic modulation reveals distinct roles of the subthalamic nucleus and its afferents in the regulation of locomotor sensitization to amphetamine in rats. Psychopharmacology 2022;239(2):353-364. [doi: 10.1007/s00213-021-05985-7] PMID: 34549316
  41. Singh S, Banta-Green C, Kingston S. Distribution of Safer Drug Smoking Supplies as a Public Health Strategy. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, January 2022
  42. Firth CL, Carlini B, Dilley J, Guttmanova K, Hajat A. Retail cannabis environment and adolescent use: The role of advertising and retailers near home and school. Health & Place 2022;75:102795. [doi: 10.1016/j.healthplace.2022.102795] PMID: 35344691 PMCID: PMC9189000
  43. Musyoka CM, Mbwayo A, Donovan DM, Mathai M. Student peer mentoring: Feasibility and acceptability of mHealth-based tool for alcohol and substance abuse prevention by peer mentors at a university in Kenya. PLOS Digital Health 2023;2(1):e0000177. [doi: 10.1371/journal.pdig.0000177] PMID: 36812633 PMCID: PMC9931292
  44. Hirchak KA, Lyons AJ, Herron JL, Kordas G, Shaw JL, Jansen K, Avey JP, McPherson SM, Donovan DM, Roll J, Buchwald D, Ries R, McDonell MG, HONOR Study Team. Contingency management for alcohol use disorder reduces cannabis use among American Indian and Alaska Native adults. Journal of Substance Abuse Treatment 2022;137:108693. [doi: 10.1016/j.jsat.2021.108693] PMID: 34952747 PMCID: PMC9086134
  45. Carlini BH, Garrett SB, Nims LN. The kids are not all right: E-cigarettes, cannabis co-use, and an emerging public health crisis: A commentary on Roberts et al. (2022). Journal of Studies on Alcohol and Drugs 2022;83(5):771-772. [doi: 10.15288/jsad.22-00167] PMID: 36136449
  46. Peavy KM, Banta-Green C. Methadone: An Old Medication with Untapped Potential. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, April 2022
  47. Kisicki A, Becker S, Chaple M, Gustafson DH, Hartzler BJ, Jacobson N, Murphy AA, Tapscott S, Molfenter T. Behavioral healthcare organizations’ experiences related to use of telehealth as a result of the COVID-19 pandemic: an exploratory study. BMC Health Services Research 2022;22:775. [doi: 10.1186/s12913-022-08114-y] PMID: 35698186 PMCID: PMC9189799
  48. Carlini BH, Garrett S, Firth C, Pinksy I. Cannabis industry marketing violations in Washington State, 2014-2019. Journal of Studies on Alcohol and Drugs 2022;83:18-26. [doi: 10.15288/jsad.2022.83.18] PMID: 35040756
  49. Merrill JE, Lopez G, Stevens AK, Singh S, Laws MB, Mastroleo N, Magille M, Monti P, Kahler CW. Discussion of alcohol consequences during a brief motivational intervention session: comparing those who do and do not increase readiness to change. Addiction Research & Theory 2022;30(4):279-287. [doi: 10.1080/16066359.2021.2021401] PMID: 37180491 PMCID: PMC10181841
  50. Lyons VH, Floyd AS, Griffin E, Wang J, Hajat A, Carone M, Benkeser D, Whiteside LK, Haggerty KP, Rivara FP, Rowhani-Rahbar A. Helping individuals with firearm injuries: A cluster randomized trial. Journal of Trauma and Acute Care Surgery 2021;90(4):722-730. [doi: 10.1097/TA.0000000000003056] PMID: 33405475 PMCID: PMC7979484
  51. Becker SJ, Murphy CM, Hartzler B, Rash CJ, Janssen T, Roosa M, Madden L, Garner BR. Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A Cluster-randomized type 3 hybrid effectiveness-implementation trial. Addiction Science & Clinical Practice 2021;16:61. [doi: 10.1186/s13722-021-00268-0] PMID: 34635178 PMCID: PMC8505014
  52. Peavy KM, Banta-Green C. Group Counseling for People in Medication Treatment for Opioid Use Disorder. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, June 2021
  53. Fiala S, Dilley J, Everson E, Firth C, Maher J. Youth exposure to marijuana advertising in Oregon’s legal retail marijuana market. Preventing Chronic Disease 2020;17:E110. [doi: 10.5888/pcd17.190206] PMID: 32975510 PMCID: PMC7553221
  54. Hirchak K, Jansen K, Lyons AJ, Herron J, Bergerson D, Shaw J, Dirks LG, Avey J, Calhoun D, Jackson C, Lauch L, Donovan DM, McPherson SM, Echo-Hawk A, Dillard D, Lillie K, Roll J, Buchwald D, McDonell MG, HONOR Study Team. Lessons shared: Implementation of a randomized clinical trial for alcohol use disorders with five American Indian and Alaska Native communities. Collaborations 2021;4(1):5 [doi: 10.33596/coll.76]
  55. Jacka B, Janssen T, Garner BR, Yermash J, Yap K, Murphy CM, Hartzler B, Becker SJ. Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder. Drug and Alcohol Dependence 2021;221:108617. [doi: 10.1016/j.drugalcdep.2021.108617] PMID: 33647590 PMCID: PMC7883735
  56. Peavy KM, Banta-Green C. Understanding and Supporting Adolescents with an Opioid Use Disorder. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, June 2021
  57. Whiteside LK, Huynh L, Morse S, Hall J, Meurer W, Banta-Green CJ, Scheuer H, Cunningham R, McGovern M, Zatzick DF. The Emergency Department Longitudinal Integrated Care (ED-LINC) intervention targeting opioid use disorder: A pilot randomized clinical trial. Journal of Substance Abuse Treatment 2021:108666. [doi: 10.1016/j.jsat.2021.108666] PMID: 34952745 PMCID: PMC9056018
  58. Parker M, Duran B, Rhew I, Margarati M, Larimer M, Donovan DM. Risk and protective factors associated with moderate and acute suicidal ideation among a national sample of Tribal College and University students, 2015-2016. Journal of Rural Health 2021;37(3):545-553. [doi: 10.1111/jrh.12510] PMID: 32894614
  59. Banta-Green C, Kingston S, Newman A. Acute Consequences of Methamphetamine Use Among Participants of Syringe Exchange Programs. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, February 2021
  60. Becker SJ, Garner BR, Hartzler BJ. Is necessity also the mother of implementation? COVID-19 and the implementation of evidence-based treatments for opioid use disorders. Journal of Substance Abuse Treatment 2021;122:108210. [doi: 10.1016/j.jsat.2020.108210] PMID: 33509413 PMCID: PMC7834027
  61. Floyd AS, Lyons VH, Whiteside LK, Haggerty KP, Rivara FP, Rowhani-Rahbar A. Barriers to recruitment, retention and intervention delivery in a randomized trial among patients with firearm injuries. Injury Epidemiology 2021;8:37. [doi: 10.1186/s40621-021-00331-z] PMID: 34304738 PMCID: PMC8311948
  62. Teadt S, Newman A. “Your ‘give a damn’ just really stops giving a damn”: Perspectives of people who use methamphetamine on reducing or stopping their use. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, October 2021
  63. Musyoka C, Mbwayo A, Donovan DM, Mathai M. mHealth-based peer mentoring for prevention of alcohol and substance abuse among first year university students: Protocol for quasi-experimental intervention. Journal of Substance Use 2021;26(1):53-59. [doi: 10.1080/14659891.2020.1766131]
  64. Dalve K, Gause E, Mills B, Floyd AS, Rivara FP, Rowhani-Rahbar A. Neighborhood disadvantage and firearm injury: does shooting location matter? Injury Epidemiology 2021;8,10. [doi: 10.1186/s40621-021-00304-2] PMID: 33678193 PMCID: PMC7938602
  65. Molfenter T, Roget N, Chaple M, Behlman S, Cody O, Hartzler B, Johnson E, Nichols M, Stilen P, Becker SJ. Use of telehealth in substance use disorder services during and after COVID-19: Online survey study. JMIR Ment Health 2021;8(2):e25835. [doi: 10.2196/25835] PMID: 33481760 PMCID: PMC7895293
  66. Schauer GL, Dilley JA, Roehler DR, Sheehy TJ, Dilley JR, Broschart SC, Holland KM, Baldwin GT, Holmes-Chavez AK, Hoots BE. Cannabis sales increases during COVID-19: Findings from Alaska, Colorado, Oregon, and Washington. International Journal of Drug Policy 2021;98:103384. [doi: 10.1016/j.drugpo.2021.103384] PMID: 34364201 PMCID: PMC9759692
  67. Roache JD, Pavlicova M, Campbell ANC, Choo T, Peavy M, Kermack AS, Nunes EV, Rotrosen J. Is extended release naltrexone superior to buprenorphine-naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trial. Alcohol: Clinical & Experimental Research 2021;45(12):2569-2578. [doi: 10.1111/acer.14729] PMID: 34698397 PMCID: PMC8722377
  68. van Tilburg MAL, Levy RL, Stoner S, Romano JM, Murphy TB, Abdullah B, Manci L, Feld AD. Mediation of outcomes for cognitive behavioral therapy targeted to parents of children with functional abdominal pain disorders. Journal of Psychosomatic Research 2021;150:110618. [doi: 10.1016/j.jpsychores.2021.110618] PMID: 34598050 PMCID: PMC8526395
  69. Carlini BH, Garrett SB, Firth C, Harwick R. Cannabis retail staff (“budtenders”) attitudes towards cannabis effect on health and experiences interacting with consumers – Washington State USA. Journal of Psychoactive Drugs 2022;29:1-9. [doi: 10.1080/02791072.2021.1900628] PMID: 33781175
  70. Fairlie AM, Jaffee AE, Davis KC, Litt DM, Kaysen D, Norris J, Lewis MA. Establishing a new measure of alcohol-related sexual consequences and examining its association to alcohol consequences among at-risk young adults. Journal of Studies on Alcohol and Drugs 2021;82(4):593-502. [doi: 10.15288/jsad.2021.82.493] PMID: 34343081 PMCID: PMC8356789
  71. Peavy KM, Banta-Green C, Owens M. Opioids and Stimulants: What Are They and How Are People Using Them? Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, April 2021
  72. Kingston S. WA State Project to Prevent Prescription Drug/Opioid Overdose: Final Report on Naloxone Distribution, September 1, 2016 – August 31, 2021. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, November 2021
  73. Peavy KM, Banta-Green C, Owens M. Helping People Who Use Opioids and Stimulants. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, April 2021
  74. Parker M, Duran B, Rhew I, Magarati M, Egashira L, Larimer M, Donovan DM. Prevalence of moderate and acute suicidal ideation among a national sample of tribal college and university students 2014–2015. Archives of Suicide Research 2021;25(3):406-423. [doi: 10.1080/13811118.2019.1691691] PMID: 31769351 PMCID: PMC7739486
  75. Banta-Green CJ, Williams J. Dramatic Increases in Opioid Overdose Deaths Due to Fentanyl Among Young People in Washington State. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, December 2021
  76. Rosa C, Marsch LA, Winstanley EL, Brunner M, Campbell ANC. Using digital technologies in clinical trials: Current and future applications. Contemporary Clinical Trials 2021;100:106219. [doi: 10.1016/j.cct.2020.106219] PMID: 33212293 PMCID: PMC8734581
  77. Shih RA, Tucker JS, Pedersen ER, Seelam R, Dunbar MS, Kofner A, Firth C, D'Amico EJ. Density of medical and recreational cannabis outlets: racial/ethnic differences in the associations with young adult intentions to use cannabis, e-cigarettes, and cannabis mixed with tobacco/nicotine. Journal of Cannabis Research 2021;3(1):28. [doi: 10.1186/s42238-021-00084-y] PMID: 34243820 PMCID: PMC8272320
  78. Hatch-Maillette MA, Peavy KM, Tsui JI, Banta-Green CJ, Woolworth S, Grekin P. Re-thinking patient stability for methadone in opioid treatment programs during a global pandemic: Provider perspectives. Journal of Substance Abuse Treatment 2021;124:108223. [doi: 10.1016/j.jsat.2020.108223] PMID: 33342667 PMCID: PMC8005420
  79. Firth CL, Baquero B, Berney R, Hoerster KD, Mooney SJ, Winters W. Not quite a block party: COVID-19 street reallocation programs in Seattle WA and Vancouver, BC. SSM - Population Health 2021;14:100769. [doi: 10.1016/j.ssmph.2021.100769] PMID: 33748391 PMCID: PMC7966863
  80. Newman A, Kingston S. Housing Program Staff Want More Training to Address Substance Use Among Residents. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, December 2021
  81. McDonell MG, Hirchak KA, Herron J, Lyons AJ, Alcover KC, Shaw J, Kordas G, Dirks LG, Jansen K, Avey J, Lillie K, Donovan D, McPherson SM, Dillard D, Ries R, Roll J, Buchwald D, HONOR Study Team. Effect of incentives on alcohol abstinence with three American Indian and Alaska Native communities: A multi-site randomized controlled trial. JAMA Psychiatry 2021;78(6):599-606. [doi: 10.1001/jamapsychiatry.2020.4768] PMID: 33656561 PMCID: PMC7931140
  82. Pedersen ER, Firth C, Rodriguez A, Shih RA, Seelam R, Kraus L, Dunbar MS, Tucker JS, Kilmer B, D'Amico EJ. Examining associations between licensed and unlicensed outlet density and cannabis outcomes from preopening to postopening of recreational cannabis outlets. American Journal on Addictions 2021;30(2):122-130. [doi: 10.1111/ajad.13132] PMID: 33378105 PMCID: PMC8157480
  83. Banta-Green CJ, Hansen RN, Ossiander EM, Wasserman CR, Merrill JO. Buprenorphine utilization among all Washington State residents’ based upon prescription monitoring program data – Characteristics associated with two measures of retention and patterns of care over time. Journal of Substance Abuse Treatment 2021;127:108446. [doi: 10.1016/j.jsat.2021.108446] PMID: 34049724
  84. Stephens KA, Weset II, Hallgren KA, Mollis B, Ma K, Donovan DM, Stuvek B, Baldwin LM. Service utilization and chronic condition outcomes among primary care patients with substance use disorders and co-occurring chronic conditions. Journal of Substance Abuse Treatment 2020;112S:49-55. [doi: 10.1016/j.jsat.2020.02.008] PMID: 32220411 PMCID: PMC7274163
  85. Musyoka CM, Mbwayo A, Mathai M, Donovan DM. Alcohol and substance use among first-year students at the University of Nairobi, Kenya: Prevalence and patterns. PLOS One 2020;15(8):e0238170. [doi: 10.1371/journal.pone.0238170] PMID: 32857791 PMCID: PMC7454962
  86. Lillie KM, Jansen KJ, Dirks LG, Lyons AJ, Alcover KC, Avey JP, Hirchak K, Herron J, Buchwald D, Donovan DM, McDonnell MG, Shaw JL. Assessing the predictive validity of the Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES) in Alaska Native and American Indian people. Journal of Addiction Medicine 2020;14(5):e241-e246. [doi: 10.1097/ADM.0000000000000661] PMID: 32371661 PMCID: PMC7541407
  87. McMahan VM, Kingston S, Newman A, Stekler JD, Glick SN, Banta-Green CJ. Interest in reducing methamphetamine and opioid use among syringe services program participants in Washington State. Drug and Alcohol Dependence 2020;216:108243. [doi: 10.1016/j.drugalcdep.2020.108243] PMID: 32911134 PMCID: PMC9632690
  88. Firth CL, Carlini BH, Dilley J, Wakefield J, Hajat A. What about equity? Neighborhood deprivation and cannabis retailers in Portland, Oregon. Cannabis 2020;3(2):157-172. [doi: 10.26828/cannabis.2020.02.003]
  89. Hood JE, Banta-Green CJ, Duchin JS, Breuner J, Dell W, Finegood B, Glick SN, Hamblin M, Holcomb S, Mosse D, Oliphant-Wells T, Shim MM. Engaging an unstably housed population with low-barrier buprenorphine treatment at a syringe services program: Lessons learned from Seattle, Washington. Substance Abuse 2020;41(3):356-364. [doi: 10.1080/08897077.2019.1635557] PMID: 31403907
  90. Carpenter KM, Torres AJ, Salmon EE, Carlini BH, Vickerman KA, Schauer GL, Bush T. Marijuana use and adherence to smoking cessation treatment among callers to tobacco quitlines. Preventing Chronic Disease 2020;17:200110. [doi: 10.5888/pcd17.200110] PMID: 32915131 PMCID: PMC7553215
  91. Firth CL, LaBrie JW, D'Amico EJ, Klein DJ, Griffin BA, Pedersen ER. Changes in cigarette, e-cigarette and cannabis use among college students studying abroad. Substance Use & Misuse 2020;55(10):1683-1691. [doi: 10.1080/10826084.2020.1756853] PMID: 32364038 PMCID: PMC7485612
  92. McMahan VM, Frank N, Buckler S, Violette LR, Baeten JM, Banta-Green CJ, Barnabas RV, Simoni J, Stekler JD. Protocol development for HMU! (HIV Prevention for Methamphetamine Users), a study of peer navigation and text messaging to promote pre-exposure prophylaxis adherence and persistence among people who use methamphetamine: Qualitative focus group and interview study. JMIR Formative Research 2020;4(9):e18118. [doi: 10.2196/18118] PMID: 32924952 PMCID: PMC7522731
  93. Pedersen ER, Firth CL, Parker J, Shih RA, Davenport S, Rodriguez A, Dunbar MS, Kraus L, Tucker JS, D'Amico EJ. Locating medical and recreational cannabis outlets for research purposes: online methods and observational study. Journal of Medical Internet Research 2020;22(2):e16853. [doi: 10.2196/16853] PMID: 32130141 PMCID: PMC7066509
  94. Haggerty KP, Carlini BH. Commentary: Understanding the intergenerational transmission of substance use and problem behavior: Implications for future research and preventive interventions. Psychology of Addictive Behaviors 2020;34(8):894-897. [doi: 10.1037/adb0000624]
  95. Hartzler B, Vandersloot D. The role of an intermediary purveyor organization in identifying and responding to workforce priorities to combat the opioid epidemic [conference abstract]. Addiction Science & Clinical Practice 2020;15(suppl2):A65. [doi: 10.1186/s13722-020-00208-4]
  96. Larimer ME, Parker M, Lostutter T, Rhew I, Eakins D, Lynch A, Walter T, Egashira L, Kipp BJ, Duran B. Perceived descriptive norms for alcohol use among tribal college students: Relation to self-reported alcohol use, consequences, and risk for alcohol use disorder. Addictive Behaviors 2020;102:106158. [doi: 10.1016/j.addbeh.2019.106158] PMID: 31830672
  97. Hildebrandt UC, Graham JC, Grant TM. Predictors and moderators of improved social-emotional functioning in mothers with substance use disorders and their young children enrolled in a relationship-based case management program. Infant Mental Health Journal 2020;41(5):677-696. [doi: 10.1002/imhj.21872] PMID: 32578238
  98. Firth CL, Hajat A, Dilley J, Braun M, Maher JE. Implications of cannabis legalization on juvenile justice outcomes and racial disparities. American Journal of Preventive Medicine 2020;58(4):562-569. [doi: 10.1016/j.amepre.2019.11.019] PMID: 32033855 PMCID: PMC7266456
  99. Hendershot CS, Dermody SS, Wardell JD, Zaso MJ, Kennedy JL, Stoner SA. OPRM1 moderates daily associations of naltrexone adherence with alcohol consumption: preliminary evidence from a mobile health trial. Alcohol: Clinical & Experimental Research 2020;44(4):983-991. [doi: 10.1111/acer.14300] PMID: 32020635 PMCID: PMC8758337
  100. Harwick R, Carlini BH, Garrett SB. A taxonomy of consumers’ perspectives on the function of cannabis in their lives: A qualitative study in WA State, USA. Journal of Psychoactive Drugs 2020;52(5):393-400. [doi: 10.1080/02791072.2020.1763522] PMID: 32501752